METHOD FOR MONITORING CRITICAL STATES DEVELOPMENT ASSOCIATED WITH INFLAMMATORY SYSTEMIC RESPONSE SYNDROME Russian patent published in 2007 - IPC G01N33/68 

FIELD: medicine.

SUBSTANCE: method involves determining myoglobin and troponin-I Troponin-I level being equal to 0.2-1 ng/ml and/or myoglobin level being equal to 60-800 ng/ml with the exception of the first 4 days after direct massive muscle tissue injury, polyorganic insufficiency development conclusion is drawn in septic and aseptic diseases associated with inflammatory systemic response syndrome. Troponin-I level being from 0.2 to 1 ng/ml shows myocardial microinjuries development. Troponin-I level being from 1 to 10 ng/ml, points out to focal destructive myocardial changes availability. Troponin-I level being higher than 10 ng/ml, large focus myocardial infarction development as secondary complications. Myoglobin level being higher than 800 ng/ml, unfavorable prognosis of septic and aseptic diseases associated with inflammatory systemic response syndrome.

EFFECT: high accuracy of monitoring.

2 tbl